Cambridge Trust’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-84
Closed -$4K 849
2022
Q2
$4K Buy
+84
New +$4.77K ﹤0.01% 754
2016
Q4
Sell
-116,682
Closed -$9.07M 265
2016
Q3
$9.07M Sell
116,682
-7,986
-6% -$645K 0.66% 54
2016
Q2
$9.72M Buy
124,668
+920
+0.7% +$73.3K 0.74% 51
2016
Q1
$10.1M Buy
123,748
+603
+0.5% +$49K 0.83% 48
2015
Q4
$11M Buy
123,145
+1,872
+2% +$159K 0.9% 47
2015
Q3
$9.32M Buy
121,273
+4,489
+4% +$375K 0.82% 45
2015
Q2
$9.77M Buy
116,784
+32,012
+38% +$2.83M 0.81% 49
2015
Q1
$7.65M Buy
+84,772
New +$7.3M 0.64% 55

Other funds holding CAH

Cambridge Trust's CAH Position: Q3 2022 in Review

Cambridge Trust sold out of Cardinal Health (CAH) in Q3 2022, closing a stake of 84 shares — an estimated $4K sold.

Cambridge Trust first reported a position in CAH in Q1 2015 and held it in 8 quarters. The position peaked at $11M in Q4 2015. 848 funds tracked by Wall St. Rank hold CAH as of Q3 2022.

  • Cambridge Trust reported no remaining Cardinal Health position as of Q3 2022 after selling out during the quarter.
  • Cambridge Trust sold 84 Cardinal Health shares in Q3 2022, an estimated $4K.
  • Cambridge Trust first reported a position in Cardinal Health in Q1 2015 and held it in 8 quarters.
  • Cambridge Trust's Cardinal Health position peaked at $11M in Q4 2015.
  • 848 funds tracked by Wall St. Rank held Cardinal Health as of Q3 2022.

Based on Cambridge Trust's 13F filing for Q3 2022, filed 8 Nov 2022.